AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

StayHappi Glimepiride+Metformin 1mg/500mg Tablet

Prescription Icon
Prescription Required

Marketer

Sarvagunaushdhi Pvt Ltd

Salt Composition

Glimepiride (1mg) + Metformin (500mg)

Overview StayHappi Glimepiride+Metformin 1mg/500mg Tablet

DiaBeta (Glimepiride/Metformin 1mg/500mg) tablets are antidiabetic medications combining two drugs to manage type 2 diabetes in adults. This combination helps regulate blood glucose. DiaBeta should be taken with food, consistently at the same time daily for optimal effectiveness. Dosage is determined by your physician and may be adjusted based on blood sugar monitoring. Continued use is crucial, even with controlled blood sugar, as discontinuation without medical consultation can lead to elevated blood glucose, potentially causing kidney problems, vision loss, neuropathy, and limb complications. Remember, this medication is part of a comprehensive diabetes management plan including diet, exercise, and weight management as advised by your doctor. Lifestyle changes are vital for diabetes control. The most frequent adverse effect is hypoglycemia (low blood sugar), characterized by sweating, dizziness, headache, and tremors. Regular meals and carrying a quick-acting glucose source (e.g., sugary snacks or juice) are essential to prevent this. Alcohol increases hypoglycemia risk and should be avoided. Other possible side effects include altered taste, nausea, diarrhea, abdominal pain, headache, and upper respiratory infections. Weight gain may occur in some individuals. DiaBeta is contraindicated in type 1 diabetes, diabetic ketoacidosis, and severe kidney or liver disease. Individuals with a history of heart disease should inform their doctor before starting this medication. Pregnant or breastfeeding women should consult their physician prior to use. Regular blood glucose checks and potential blood tests to monitor blood cell counts and liver function are necessary.

Primary Ingredients of StayHappi Glimepiride+Metformin 1mg/500mg Tablet

There is no text provided to rephrase.

Uses of StayHappi Glimepiride+Metformin 1mg/500mg Tablet

Managing type 2 diabetes

Major Benefits of StayHappi Glimepiride+Metformin 1mg/500mg Tablet:

Follow your doctor's instructions precisely regarding the dosage and treatment length for this medication. Ingest the StayHappi Glimepiride+Metformin 1mg/500mg tablet whole; do not chew, crush, or fracture it. Administer this medication with food.

Common Side effects of StayHappi Glimepiride+Metformin 1mg/500mg Tablet:

  • Headache
  • Hypoglycemia (low blood glucose level)
  • Nausea
  • Diarrhea

How to use StayHappi Glimepiride+Metformin 1mg/500mg Tablet:

Follow your doctor's instructions precisely regarding dosage and treatment length for StayHappi Glimepiride+Metformin 1mg/500mg Tablets. Ingest the tablets whole; avoid crushing, chewing, or breaking them. These tablets should be taken with meals.

How StayHappi Glimepiride+Metformin 1mg/500mg Tablet works:

StayHappi Glimepiride/Metformin 1mg/500mg tablets combine the actions of two distinct antidiabetic agents. Glimepiride, a sulfonylurea, stimulates the pancreas to release more insulin, thus reducing blood sugar. Metformin, a biguanide, acts in a threefold manner: decreasing hepatic glucose production, slowing intestinal glucose uptake, and enhancing insulin sensitivity.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Consuming alcohol while taking StayHappi Glimepiride+Metformin 1mg/500mg tablets is dangerous.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of StayHappi Glimepiride+Metformin 1mg/500mg tablets during pregnancy may pose risks. While human research is limited, animal studies indicate potential harm to a fetus. A physician will assess the advantages against possible dangers prior to prescribing. Seek medical advice before use.

Breast feedingBreast feedingUNSAFE

Lactation is contraindicated with StayHappi Glimepiride+Metformin 1mg/500mg tablets due to potential infant harm from the medication. Evidence indicates a risk of neonatal toxicity.

DrivingDrivingCAUTION

Impaired driving is possible with abnormally low or high blood glucose levels. Refrain from driving if such symptoms arise.

KidneyKidneyCAUTION

Patients with kidney impairment should use StayHappi Glimepiride+Metformin 1mg/500mg tablets cautiously, potentially requiring dosage modification under medical supervision. This medication is contraindicated in those with severe kidney disease. Regular kidney function monitoring is recommended during treatment.

LiverLiverCAUTION

Patients with liver impairment should use StayHappi Glimepiride+Metformin 1mg/500mg tablets cautiously, potentially requiring dosage modification. Medical consultation is advised. Individuals with mild to moderate liver disease should typically begin with a low dose; however, this medication is unsuitable for those with severe hepatic dysfunction.

What if you forget to take StayHappi Glimepiride+Metformin 1mg/500mg Tablet :

Should you forget a StayHappi Glimepiride+Metformin 1mg/500mg Tablet dose, administer it immediately upon recollection. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About StayHappi Glimepiride+Metformin 1mg/500mg Tablet

LabelValue
Developing Habits No.
Treatment Category Diabetes Management

FAQs on StayHappi Glimepiride+Metformin 1mg/500mg Tablet

Store this medication in its original, tightly closed container, following the storage instructions on the label or packaging. Discard any unused medication and ensure it's inaccessible to children, pets, and others.
StayHappi Glimepiride+Metformin 1mg/500mg Tablets can cause lactic acidosis, a serious medical emergency resulting from excess blood lactic acid (also called Metformin-associated lactic acidosis or MALA). This rare but potentially harmful side effect is more likely in patients with kidney disease, older adults, or those who consume significant amounts of alcohol. Symptoms include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and a slow heart rate. If you experience these, discontinue use and seek immediate medical attention.
StayHappi Glimepiride/Metformin 1mg/500mg tablets combine glimepiride and metformin to treat type 2 diabetes mellitus in adults. This combination improves blood glucose control when used with diet and exercise. Glimepiride stimulates insulin release from the pancreas, while metformin reduces liver glucose production and enhances insulin sensitivity. This medication is unsuitable for type 1 diabetes.
StayHappi Glimepiride+Metformin 1mg/500mg Tablets may cause common side effects such as hypoglycemia, altered taste, nausea, stomach pain, diarrhea, and headache. Rare but serious side effects include lactic acidosis. Prolonged use can also result in vitamin B12 deficiency.
Prolonged use of StayHappi Glimepiride+Metformin 1mg/500mg Tablets can lead to Vitamin B12 deficiency by impairing its absorption. This deficiency, if left untreated, may result in anemia, neurological issues such as tingling, numbness in extremities, weakness, urinary dysfunction, cognitive changes, and ataxia. To mitigate this risk, annual supplemental Vitamin B12 is recommended by some researchers.
StayHappi Glimepiride+Metformin 1mg/500mg Tablets can cause low blood sugar (hypoglycemia), manifesting as nausea, headache, irritability, hunger, sweating, dizziness, rapid heartbeat, anxiety, or shakiness. This risk increases with missed meals, alcohol consumption, excessive exercise, or concurrent use of other diabetes medications. Regular blood sugar monitoring is crucial. Always carry a fast-acting sugar source, such as glucose tablets, honey, or fruit juice.
Combining StayHappi Glimepiride+Metformin 1mg/500mg tablets with alcohol is unsafe. This combination can dangerously lower blood sugar (causing hypoglycemia) and raise the risk of lactic acidosis.
StayHappi Glimepiride+Met...
23
MRP 27
14% off